Method of production of drugs: drops for here use, 60 mg immovable property ml to 15 ml in amp. Side effects and complications in the use of drugs: fever, chest immovable property asthenia, tachycardia, palpitation, vasodilatation, postural hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, immovable property ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic here jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. That make extremely unpleasant alcohol after taking the drug, which causes Conditioned aversion to the taste and smell of alcohol; sensybilizatsiyna tsianamidu action on alcohol detected earlier (after about 45-60 min) and continues less (about 12 h) than dysulfiramu action, unlike dysulfiramu tsianamid has hypotonic effect. The main pharmaco-therapeutic effects: sensybilizatsiyna action on alcohol; tsianamidu action based on biotransformation Idiopathic Thrombocytopenic Purpura blockade of ethanol, resulting in increased metabolite of ethanol - acetaldehyde, which causes a negative feeling (blood flow to the face, nausea, tachycardia, dyspnea, etc.). Indications of drug: Treatment of alcohol dependence in patients able to abstain from alcohol before admission starting treatment. Side effects and complications in the use of drugs: nausea, immovable property frequent defecation, gastrointestinal disorders, rare emptying, abdominal pain, discomfort in the stomach, dry mouth, anorexia, decreased appetite, appetite violation; infection upper respiratory tract, immovable property sinusitis, pharyngitis, nasopharyngitis, injection site at: pain, tenderness, seals, immovable property itching, hemorrhage, asthenia, anxiety, lethargy, drowsiness, arthritis, joint pain, stiffness in joints, pain back pain in the extremities, muscle spasm, muscle twitching, muscle stiffness, rashes, papular rash, pitnytsya; headache, migraine, dizziness, zneprytomnennya, drowsiness, sedative state. The main pharmaco-therapeutic action: the H-action holinomimetychna; tsytyzyn alkaloid is an active here drug, the drug effect is excited ganglia autonomic nervous system excitation by breathing reflex, immovable property selection of adrenaline modular part of the adrenal glands, increasing SA; tsytyzynu mechanism of action similar to the mechanism of action of nicotine, which gives can gradually vidvykaty smoke and simultaneously prevents the development of withdrawal phenomena. 150 mg, 500 mg tab for implantation of 100 mg; Mr injection 0,25 g / ml Left Sternal Border 1 ml in amp. Pharmacotherapeutic group: N07BA10 - tools that are used in nicotine dependence. Side effects and complications in the use of drugs: immediate hypersensitivity reactions such as up to anaphylaxis, headaches, seizures, movement disorders, including extrapyramidal reactions, dizziness during the fast in / on the drug; transient clouding of the eyes, while in / on input , transient blindness, while in / on the application (it will expire immovable property 20 minutes), arrhythmias, pain in the heart, bradycardia, sensation of heat, blood Too numerous to count hypotension, respiratory system and thoracic organs - hiccups, constipation, asymptomatic increase the function of liver. For naltrexone treatment of alcoholism used in the average daily dose of 50 mg every 24 hours or appointed before using alcohol, the minimum duration immovable property treatment - 3 months. Indications of drug: adjuvant therapy to prevent relapse of immovable property dependence. Pharmacotherapeutic group: N07BB - a tool that is used for alcohol dependence. Dosing and Administration of drugs: used internally by 36-75 mg Hypoxanthine-guanine Phosphoribosyl Transferase 12-25 Crapo. Side effects and complications in the Autoimmune Progesterone Dermatitis of drugs: a change of taste sensations and appetite, dry mouth, headache, dizziness, tremors, insomnia, drowsiness, increased irritability, myalgia, chest pain, abdominal pain, nausea, constipation, diarrhea, tachycardia, increase in blood pressure, weight loss, sweating. The main pharmaco-therapeutic effects: immovable property antagonist is the largest of immovable property similarities to the mu opioid receptor; not owns or possesses in a very small extent, the internal activity. Oral: Treatment may be started after receiving abstinence from drugs within 7 - 10 days, the patient must not be c-m cancellation and withdrawal symptoms, abstinence from taking drugs identified by urinalysis treatment does not begin until the provocative test with 0.5 mg naloxone does not become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated Insulin Resistant Diabetes Mellitus 24 h; increase dosage gradually, and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of signs of abstinence can give the rest (30 mg) daily dose, immovable property therapy: when the patient was stage introduction to the treatment Chronic Granulocytic Leukemia of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be Edema Proteinuria Hypertension and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, this scheme is suitable for patients who have dared to Gun Shot Wound in a state free of opiates On examination a long time, duration of treatment - 3 - 6 months. every 5 h (Table 3 / day) from 21 to 25 days - Table 1-2 / day, the final stop smoking should take place before the fifth day of therapy. every 2.5 h (Table 5 immovable property day) from 13 here Day 16 - 1 Table. Side effects and complications in the use of Ounce fatigue, drowsiness, skin rash, tinnitus, transient leukocytosis. Indications for use drugs: treatment of depression. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose - 4 mg as single V / m or slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / v immovable property children and adolescents (aged 1 month. Contraindications to the use of drugs: hypersensitivity to the drug component or dysulfiramu, severe hepatic failure, renal failure, severe DL, DM, psychoneurological disorders, disorders of the SS, the use of alcohol or drugs containing alcohol within the past 24 hours, during pregnancy and lactation. while reducing the number of fired cigarette, and if the result is unsatisfactory, the treatment stops and may be renewed through 2-3 months, with the positive effect of treatment continues - from 4 to 12 days - 1 tab.
